Vor Biopharma (VOR) director receives 42,658 stock options at $20.10 strike
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Vor Biopharma director David Zaccardelli received a new stock option grant. The award covers 42,658 options to buy Vor Biopharma common stock at an exercise price of $20.10 per share and expires on July 6, 2036. These options will vest in 36 equal monthly installments beginning on August 7, 2026, contingent on his continued service with the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
ZACCARDELLI DAVID
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 42,658 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 42,658 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 42,658 options
Exercise price: $20.10 per share
Expiration date: July 6, 2036
+3 more
6 metrics
Options granted
42,658 options
Stock Option (Right to Buy) grant to director
Exercise price
$20.10 per share
Strike price for Vor Biopharma common stock
Expiration date
July 6, 2036
Option term end date
Underlying shares
42,658 shares
Common stock underlying the options
Vesting period
36 monthly installments
Beginning August 7, 2026, subject to continued service
Post-grant derivative holdings
42,658 options
Total derivative securities following the transaction
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 20.1000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-07-06T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"The shares shall vest and become exercisable in a series of 36 successive equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
underlying security financial
"underlying_security_title: Common Stock"
FAQ
What did Vor Biopharma (VOR) disclose about David Zaccardelli in this Form 4?
Vor Biopharma reported that director David Zaccardelli received a stock option grant for 42,658 shares. The options give him the right to buy common stock at $20.10 per share, subject to a multi-year vesting schedule tied to continued service.
How many Vor Biopharma (VOR) stock options were granted to David Zaccardelli?
David Zaccardelli was granted stock options covering 42,658 shares of Vor Biopharma common stock. These options represent a new compensation award and are scheduled to vest over time, rather than being immediately exercisable on the grant date.
What is the exercise price of David Zaccardelli’s Vor Biopharma (VOR) stock options?
The exercise price of David Zaccardelli’s stock options is $20.10 per share. This is the fixed price he must pay to purchase Vor Biopharma common shares when vested options are eventually exercised in the future.
When do David Zaccardelli’s Vor Biopharma (VOR) stock options start vesting?
The options begin vesting on August 7, 2026. Vesting then continues in 36 equal monthly installments, meaning the award becomes exercisable gradually over three years, as long as he continues serving the company on each vesting date.
When do David Zaccardelli’s Vor Biopharma (VOR) stock options expire?
The stock options granted to David Zaccardelli expire on July 6, 2036. After this expiration date, any unexercised options will lapse, so they must be both vested and exercised before that deadline to convert into common shares.
Are David Zaccardelli’s Vor Biopharma (VOR) options immediately exercisable?
No, the options are not immediately exercisable. They vest and become exercisable in 36 equal monthly installments starting August 7, 2026, and each installment requires David Zaccardelli to remain in service on the respective vesting date.